AI Science Tracker

Machine-learning-assisted screening yields an experimentally active FtsZ inhibitor candidate

Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, Jiangxi Science and Technology Normal University; Jiangxi University of Traditional Chinese Medicine Cancer Research Center · 23 Jul 2024 · medicine

Discovery

Machine-learning-assisted screening yields an experimentally active FtsZ inhibitor candidate

A fused machine-learning and virtual-screening workflow narrowed compounds from three libraries to five candidate FtsZ inhibitors for bioactivity evaluation. The compound T3995 inhibited Staphylococcus aureus ATCC 6538 and Bacillus subtilis ATCC 9732 in reported assays, with MIC values of 32 and 2 μg/mL, respectively. Morphology and FtsZ-polymerization assays supported FtsZ-related antibacterial activity.

Technology: ROC-guided machine-learning selection combined with virtual screening, clustering and binding-model analysis

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: The compound T3995 inhibited Staphylococcus aureus ATCC 6538 and Bacillus subtilis ATCC 9732 in reported assays, with MIC values of 32 and 2 μg/mL, respectively.
  • Still unknown: Evidence is early in-vitro antibacterial activity and indirect support for an FtsZ-related mechanism; the abstract does not report direct target-binding measurements or in-vivo efficacy. Hemolysis was reported as safe at or below 16 μg/mL, while the MIC against S. aureus was 32 μg/mL, so this does not establish a therapeutic safety margin. The paper’s 2025 issue date follows its 2024 online publication date; the source-publication date here is the documented first online publication (23 July 2024).
  • AI role: ROC-guided ML filtered candidates from three libraries; virtual screening of acquired compounds followed, then clustering and binding-model analysis prioritized five hits. Researchers performed growth, time-kill, cell-morphology, FtsZ-polymerization and hemolysis assays, including testing T3995.

Evidence sources: https://pubmed.ncbi.nlm.nih.gov/39043879/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: at percentile 58 of works of the same type, year and subfield (OpenAlex work metrics, 4 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.